MTOR and neoplasm: Multi-region tumor sampling, as first suggested by Gerlinger et al. (2012), revealed parallel evolution of distinct somatic mutations, leading to activation of the mTOR pathway in independent areas of the tumor in three of the five cases investigated (Voss et al., 2014).